MENU
+Compare
FBT
ETF ticker: NYSE ARCA
AS OF
Jun 4, 04:50 PM (EDT)
Price
$163.44
Change
+$0.76 (+0.47%)
Net Assets
1.03B

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FBT with price predictions
Jun 03, 2025

FBT in +0.87% Uptrend, rising for three consecutive days on June 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FBT advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on FBT as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FBT just turned positive on May 16, 2025. Looking at past instances where FBT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

FBT moved above its 50-day moving average on May 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FBT crossed bullishly above the 50-day moving average on May 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 215 cases where FBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where FBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Exact Sciences Corp (NASDAQ:EXAS), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotech ETF ETF is 25.37B. The market cap for tickers in the group ranges from 1.66B to 151.69B. AMGN holds the highest valuation in this group at 151.69B. The lowest valued company is VCYT at 1.66B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 13%. For the same ETF, the average monthly price growth was 44%, and the average quarterly price growth was 26%. BNTX experienced the highest price growth at 17%, while REGN experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was 50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 67
Price Growth Rating: 58
SMR Rating: 66
Profit Risk Rating: 63
Seasonality Score: 40 (-100 ... +100)
View a ticker or compare two or three
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
First Trust Exchange-Traded Fund1001 Warrenville Road, Suite 300Lisle
Phone
630-241-4141
Web
www.ftportfolios.com